Today, we are pleased to share a podcast interview between Kyle Valgardson, host of the ‘Why Science Podcast’. In this series, Kyle explores the reasons why life science researchers and industry professionals are driven to do the work they do and why the general public should understand and care about their discoveries and breakthroughs.
In Kyle’s words… “What if the key to treating disease wasn’t to overpower the body—but to work with its existing systems? In this episode, I sit down with Frank Borriello, founder of Alloplex Biotherapeutics, to explore a new approach to therapy—one that uses natural immune regulation instead of chemical force. We talk through the science behind Alloplex’s platform, how it’s aiming to activate—not suppress—the body’s own healing potential, and why that shift in mindset could change everything from how we treat cancer to how we think about drug development.
“Frank’s not just a scientist or a strategist—he’s someone with a lived stake in the problem. His personal experience with loss gives him a proximity-driven insight that makes this work feel urgent, not theoretical.”
“If you’re interested in biotech, systems thinking, or just want to hear from someone who’s building differently—this one’s worth your time.”
Note: This interview was recorded before the end of the first-in-human clinical trial of ‘SUPLEXA’; when final data including its findings of a complete response (CR), partial responses (PR) and long term stable disease (SD) had yet to emerge.
Duration: 56 minutes.
Interview starts around: 1 min 22 secs
To request interviews, high res images or other materials, media are asked to:
Email: media@alloplexbio.com
Attn: Lesley White, Alloplex Australia
For media requests on deadline during USA Eastern hours, please call: +1-781-281-2013
